CME Corner

This activity has expired. CME/CE credit is no longer available and the following content may not be available or may not be up-to-date. For a list of current activities that offer CME/CE credit, click here.

Program Detail

Release Date: May-22-14
Credit Expiration Date: May-22-15


Michael T. Corjulo, APRN, CPNP, AE-C
Children’s Medical Group
Hamden, CT
President, Association of School Nurses of Connecticut

Tami Renee Kochan, MSN, CPNP, AE-C
Woodburn Pediatrics
Woodburn, OR

Credit Hours




Program Description

Food allergy is an immune-based disease that has increased in the US in recent years according to several national health surveys. The prevalence of reported food allergy increased 18% from 1997 to 2007, and it is now estimated to affect 5% of children under the age of 5 years. Food allergy occurs most often in the first 3 years of life. The most common food allergens are eggs, milk, peanuts, tree nuts, soy, wheat, crustacean shellfish, and fish. These allergens cause 90% of childhood allergic reactions. Symptoms range from mild to life-threatening (anaphylaxis). There is no cure or treatment for allergies, and symptoms are treated as they appear. Prevention is, therefore, crucial. Food allergy is associated with severe asthma, atopic dermatitis, and eosinophilic esophagitis.

A number of challenges face clinicians, including making an accurate diagnosis of food allergy (versus food intolerance) and choosing among different management strategies to avoid the development of symptoms in children diagnosed with food allergy and to avoid the development of food allergy in at-risk infants. Guidelines have been developed to help standardize diagnosis and treatment of food allergy according to recommended consensus practice. With the recent increase of childhood food allergy, it is crucial that pediatric nurse practitioners (NPs), who are often the first to assess these children, fully understand the best strategies for diagnosis and treatment. Ultimately, the goal is to reduce the number of infants and children who experience symptoms—serious or otherwise—in order to improve quality of life for these patients and their families.

Program Developer/Facilitator

This activity is jointly provided by the National Association of Pediatric Nurse Practitioners and MCM Education.

Target Audience

This activity is designed for pediatric nurse practitioners and other clinicians with an interest in this topic.

Learning Objectives

Upon completion of this educational activity, the participant should be able to:

  1. Describe signs and symptoms of pediatric food allergy compared with commonly mistaken signs and symptoms of pediatric food allergy.
  2. Outline NIAID recommendations for avoiding allergens in IgE-mediated and non-IgE-mediated food allergy.
  3. Review appropriate indications for each type of infant formula available to non-breastfed infants.


It is the policy of the National Association of Pediatric Nurse Practitioners to ensure balance, independence, objectivity and scientific rigor in all of its educational activities including those which are sponsored and cosponsored. All faculty are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation. The intent of this disclosure is not to prevent a presenter with significant financial interest or other relationship from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speaker's interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.

Mr. Corjulo has no relevant financial conflicts to disclose.
Ms. Kochan has no relevant financial conflicts to disclose.

Credit Statements

This program is accredited for 0.5 NAPNAP CE contact hours per the National Association of Pediatric Nurse Practitioners Continuing Education Guidelines.

Commercial Support Statements

Supported through a restricted educational grant from Abbott Nutrition, a division of Abbott Laboratories, Inc.


Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers

  1. Please turn off all pop-up blockers to allow access to the educational activity.
  2. Click on the "Start program" icon at the bottom of this page. If you are not already registered as a user of this website, this will bring you to the login/registration page where you will be able to register as a new member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen.
  3. The next screen will permit you to check for or download the Flash player required to run this program and to begin the program presentation. The activity will take approximately 30 minutes to complete.
  4. After you have finished reviewing the activity, click on the "Post-test" button.
  5. Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen.

Certificate Fee



©2014, MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the National Association of Pediatric Nurse Practitioners, or Abbott Nutrition. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.

By clicking START PROGRAM I acknowledge that I have read the CME/CE information above.

Main Menu